Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Short Communication

Implementation of the QbD Approach to the Development and Validation of an Analytical Method for Alpha-beta Arteether

Author(s): Neha Bajwa, Shipra Mahal, Jitender Madan and Ashish Baldi*

Volume 20, Issue 9, 2023

Published on: 21 October, 2022

Page: [1414 - 1425] Pages: 12

DOI: 10.2174/1570180819666220826112814

Price: $65

Abstract

Background: The development of effective, cost-effective, robust, sensitive, and specific analytical techniques for analyzing drug(s), degradation product(s), and contaminants in dosage forms and biological samples are constantly required as part of the pharmaceutical product life-cycle. Adopting systematic analytical development methodologies such as quality by design (QbD) is particularly advantageous for enhancing method performance since analytical method development encompasses a number of variables that are significant in explaining variability in method performance. Analytical Quality by Design (AQbD) is a standardised method to process validation that covers all aspects of an analytical procedure. It comprises determining the analytical target profile (ATP), identifying critical method parameters or variables, and selecting critical method attributes (CMAs) or qualities.

Objective: Spectroscopic and chromatographic methods were developed, conferring the Quality by Design (QbD) tactic as per ICH Q8(R2) guidelines for analytical method development of α-β-arteether.

Methods: Understanding dependent variables, various factors, and their interaction effects through the desired series of experiments on the answers to be examined is referred to as QbD. Various variable factors were detected using the Ishikawa diagram. As a result, many essential factors for chromatography methods were investigated. The desired set of experiments on the answers to be evaluated was used to comprehend dependent variables, various factors, and their interaction effects using Design-Expert software version 13. Statistical research such as fractional factorial designs and Plackett-Burman were employed for this. The QbD methodology was used to establish a durable, precise, and accurate HPLC analytical method for arteether.

Results: The findings of the Plackette Burman research were studied, and the influence of each parameter on the answers was analysed using an overlay plot using Design Expert 13's statistical software. Mobile phase (Acetonitrile: water), column C18250nmX4.6mm, column temperature 300 οC, wavelength: 254 nm, injection volume 20l/min, run time 10 mins, detector waters 2489 UV/Visible detector, retention time 4.149 are among the critical parameters estimated for the development of an analytical method for α,β- arteether.

Conclusion: The analytical method developed by the QbD approach was validated according to ICH Q2(R1) guidelines, and it was found that the developed analytical method is robust and specific.

Keywords: Design of Experiments, α-β -Arteether, HPLC, Analytical Method development, Chromatography, Quality by Design.

« Previous
Graphical Abstract

[1]
Group ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice, ICH1997.
[2]
ICH Topic Q2 (R1). ICH harmonized tripartite guideline. Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH ’94), Validation of Analytical Procedures, ICH1994.
[3]
ICH Topic Q9. ICH harmonized tripartite guideline. Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH ’94), Quality Risk Management, ICH2005.
[4]
The United States Pharmacopoeia 27, the National Formulary 22. United States Pharmacopoeial Convention, Asian, ICH2004.
[5]
Khamanga, S.M.; Walker, R.B. The use of experimental design in the development of an HPLC-ECD method for the analysis of captopril. Talanta, 2011, 83(3), 1037-1049.
[http://dx.doi.org/10.1016/j.talanta.2010.11.025] [PMID: 21147355]
[6]
Yu, L.X. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm. Res., 2008, 25(4), 781-791.
[http://dx.doi.org/10.1007/s11095-007-9511-1] [PMID: 18185986]
[7]
Gavan, A.; Porfire, A.; Marina, C. TOMUŢĂ, I. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach. Acta Pharm., 2017, 67(1), 53-70.
[http://dx.doi.org/10.1515/acph-2017-0009] [PMID: 28231048]
[8]
Vasselle, B.; Gousset, G.; Bounine, J-P. Development and validation of a high-performance liquid chromatographic stability-indicating method for the analysis of Synercid in quality control, stability and compatibility studies. J. Pharm. Biomed. Anal., 1999, 19(5), 641-657.
[http://dx.doi.org/10.1016/S0731-7085(98)00242-8] [PMID: 10698530]
[9]
Alemad, A.; Al-Absi, M.; Alagbarri, S.; Al-Nowihi, M. Formulation by design approach for effervescent granules of vitamin C using statistical optimization methodologies. J. Appl. Pharm. Res., 2020, 8(4), 62-69.
[http://dx.doi.org/10.18231/j.joapr.2020.v.8.i.4.62.69]
[10]
Bansal, S.; Beg, S.; Asthana, A.; Garg, B.; Asthana, G.S.; Kapil, R.; Singh, B. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride. Drug Deliv., 2016, 23(2), 437-451.
[http://dx.doi.org/10.3109/10717544.2014.916771] [PMID: 24865292]
[11]
Pang, X. Quality Improvement with PFMEA in a Manufacturing System; Morehead State University, 2018.
[12]
Esbensen, K.H.; Geladi, P. Principal component analysis: Concept, geometrical interpretation, mathematical background, algorithms, history, practice. Comprehensive chemometrics; Brown, S.D.; Tauler, R.; Walczak, B., Eds.; Elsevier: Netherlands, Oxford, 2009, pp. 211-226.
[http://dx.doi.org/10.1016/B978-044452701-1.00043-0]
[13]
Kochling, J.; Wu, W.; Hua, Y.; Guan, Q.; Castaneda-Merced, J. A platform Analytical Quality by Design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. J. Pharm. Biomed. Anal., 2016, 125, 130-139.
[http://dx.doi.org/10.1016/j.jpba.2016.03.031] [PMID: 27017571]
[14]
Mishra, S.M.; Rohera, B.D. An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine. Pharm. Dev. Technol., 2017, 22(7), 889-903.
[http://dx.doi.org/10.1080/10837450.2016.1199566] [PMID: 27346282]
[15]
Peraman, R.; Bhadraya, K.; Padmanabha Reddy, Y. Analytical quality by design: A tool for regulatory flexibility and robust analytics. Int. J. Anal. Chem., 2015, 2015, 868727.
[http://dx.doi.org/10.1155/2015/868727] [PMID: 25722723]
[16]
Orlandini, S.; Pinzauti, S.; Furlanetto, S. Application of quality by design to the development of analytical separation methods. Anal. Bioanal. Chem., 2013, 405(2-3), 443-450.
[http://dx.doi.org/10.1007/s00216-012-6302-2] [PMID: 22941176]
[17]
Terzić, J.; Popović, I.; Stajić, A.; Tumpa, A.; Jančić-Stojanović, B. Application of analytical quality by design concept for bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method. J. Pharm. Biomed. Anal., 2016, 125, 385-393.
[http://dx.doi.org/10.1016/j.jpba.2016.04.022] [PMID: 27131148]
[18]
Szoleczky, R.; Budai-Szűcs, M.; Csányi, E.; Berkó, S.; Tonka-Nagy, P.; Csóka, I.; Kovács, A. Analytical Quality by Design (AQbD) approach to the development of in vitro release test for topical hydrogel. Pharmaceutics, 2022, 14(4), 707.
[http://dx.doi.org/10.3390/pharmaceutics14040707] [PMID: 35456541]
[19]
Parab Gaonkar, V.; Mannur, V.K.; Hullatti, K. Quality assessment and analytical quality by design-based RP-HPLC method development for quantification of Piperine in Piper nigrum L. Fut. J. Pharma. Sci., 2022, 8(1), 16.
[http://dx.doi.org/10.1186/s43094-022-00405-9]
[20]
Veeran, M.G.; Thomas, R.R.; Ramakrishnan, R.; Aprem, A.S. Quality-by-design approach for optimization and processing of PLGA polymer film by hot melt extrusion. J. Pharm. Innov., 2022. [Epub Ahead of Print]
[http://dx.doi.org/10.1007/s12247-021-09600-2]
[21]
Williams, C.; Neil, R.; Cropley, B.; Woodman, T.; Roberts, R. A systematic review of sport-based life skills programs for young people: The quality of design and evaluation methods. J. Appl. Sport Psychol., 2022, 34(2), 409-435.
[http://dx.doi.org/10.1080/10413200.2020.1792583]
[22]
Adams, K.P.; Vosti, S.A.; Mbuya, M.N.N.; Friesen, V.M.; Engle-Stone, R. Update on analytical methods and research gaps in the use of household consumption and expenditure survey data to inform the design of food-fortification programs. Adv. Nutr., 2022, 13(3), 953-969.
[http://dx.doi.org/10.1093/advances/nmac021] [PMID: 35254392]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy